J. Dome

发表

Predicting Relapse in Favorable Histology Wilms Tumor Using Gene Expression Analysis: A Report from the Renal Tumor Committee of the Children's Oncology Group

Norman Breslow, Chiang-Ching Huang, Irene B Helenowski, 2009, Clinical Cancer Research.

Amplification and Overexpression of CACNA1E Correlates with Relapse in Favorable Histology Wilms' Tumors

Kathy Pritchard-Jones, Chris Jones, Boo Messahel, 2006, Clinical Cancer Research.

Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors.

Richard A. Moore, D. Wheeler, D. Gerhard, 2015, Cancer cell.

Molecular Targeted Therapy for Wilms’ Tumor

J. Dome, J. Geller, 2010 .

Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group

Richard A. Moore, D. Wheeler, D. Gerhard, 2016, Clinical Cancer Research.

Wilms Tumor-Nephroblastoma

J. Dome, A. Verschuur, M. V. Nelson, 2018, Rare Kidney Tumors.

A unique subset of low-risk Wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: A Children’s Oncology Group study

D. Gerhard, S. Gadd, J. Dome, 2018, PloS one.

A Children's Oncology Group and TARGET Initiative Exploring the Genetic Landscape of Wilms Tumor

Qing-Rong Chen, Richard A. Moore, Daoud Meerzaman, 2017, Nature Genetics.

Risk stratification for wilms tumor: current approach and future directions.

J. Dome, E. Perlman, N. Graf, 2014, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Recent advances in Wilms tumor genetics

M. Coppes, J. Dome, 2002, Current opinion in pediatrics.

Significance of pleural effusion in neuroblastoma

A. Davidoff, L. McGregor, J. Khoury, 2007, Pediatric blood & cancer.

Wilms tumour: prognostic factors, staging, therapy and late effects

P. Babyn, J. Dome, P. Grundy, 2007, Pediatric Radiology.

Telomerase activity and prognosis in primary breast cancers.

J. Marks, S. Sukumar, L. Carey, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dynamics of the endoplasmic reticulum in living non-muscle and muscle cells.

J. Dome, J. Sanger, J. W. Sanger, 1989, Cell motility and the cytoskeleton.

Unusual cleavage furrows in vertebrate tissue culture cells: insights into the mechanisms of cytokinesis.

J. Dome, J. Sanger, J. W. Sanger, 1998, Cell motility and the cytoskeleton.

Chemotherapy and Multidisciplinary Approaches to Pediatric Sarcomas

J. Dome, H. Meany, A. Kim, 2017 .

Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2

A. Naranjo, J. Dome, E. Perlman, 2015, Cancer.

Renal function outcomes in patients treated with nephron sparing surgery for bilateral Wilms tumor.

M. Williams, A. Davidoff, J. Dome, 2007, The Journal of urology.

Image based feasibility of renal sparing surgery for very low risk unilateral Wilms tumors: a report from the Children's Oncology Group.

J. Dome, P. Ehrlich, K. Gow, 2013, The Journal of urology.

Margin status and tumor recurrence after nephron-sparing surgery for bilateral Wilms tumor.

M. Williams, A. Davidoff, L. McGregor, 2013, Journal of pediatric surgery.

Overall Survival and Renal Function of Patients With Synchronous Bilateral Wilms Tumor Undergoing Surgery at a Single Institution.

M. Williams, D. Green, A. Davidoff, 2015, Annals of surgery.

Outcome of Wilms tumor patients with bone metastasis enrolled on National Wilms Tumor Studies 1‐5: A report from the Children's Oncology Group

J. Dome, Yeonil Kim, Yueh-Yun Chi, 2018, Pediatric blood & cancer.

Overall Survival and Renal Function of Patients With Synchronous ng Surgery at a Single Institution Bilateral Wilms Tumor Undergoi

M. Williams, D. Green, A. Davidoff, 2015 .

Primary nephrectomy and intraoperative tumor spill: report from the Children's Oncology Group (COG) renal tumors committee.

A. Naranjo, Mike K. Chen, J. Dome, 2013, Journal of pediatric surgery.

Evaluation of diagnostic performance of CT for detection of tumor thrombus in children with Wilms tumor: A report from the Children's Oncology Group

James R. Anderson, K. Karolczuk, J. Dome, 2012, Pediatric blood & cancer.

Reply to Wilms tumor and breast cancer

J. Dome, J. Dean, 2015, Cancer.

Analysis of cell division using fluorescently labeled actin and myosin in living PtK2 cells.

J. Dome, J. Sanger, J. W. Sanger, 1989, Cell motility and the cytoskeleton.

Treatment of relapsed Wilms tumors: lessons learned

J. Dome, N. Graf, C. Bergeron, 2009, Expert review of anticancer therapy.

Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration.

K. Pritchard-Jones, J. Dome, N. Graf, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Incidence and outcomes of patients with late recurrence of Wilms' tumor

K. Pritchard-Jones, J. Dome, H. van Tinteren, 2013, Pediatric blood & cancer.

Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533

B. Crompton, A. Nag, A. Thorner, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Imaging of renal medullary carcinoma in children and young adults: a report from the Children’s Oncology Group

J. Sandberg, S. Servaes, J. Dome, 2017, Pediatric Radiology.

Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors

Jing Ma, X. Su, J. Khoury, 2008, Cancer.

Comprehensive renal function evaluation in patients treated for synchronous bilateral Wilms tumor.

M. Williams, D. Green, A. Davidoff, 2017, Journal of pediatric surgery.

FDG positron emission tomography/computed tomography studies of Wilms’ tumor

J. Dome, N. Daw, M. Gelfand, 2010, European Journal of Nuclear Medicine and Molecular Imaging.

Clinical significance of pulmonary nodules detected by CT and Not CXR in patients treated for favorable histology Wilms tumor on national Wilms tumor studies‐4 and ‐5: A report from the Children's Oncology Group

N. Breslow, James R. Anderson, D. Green, 2012, Pediatric blood & cancer.

Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study.

M. Coppes, M. Chintagumpala, J. Dome, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Feasibility of using CT volume as a predictor of specimen weight in a subgroup of patients with low risk Wilms tumors registered on COG Study AREN03B2: implications for central venous catheter placement.

A. Naranjo, J. Dome, P. Ehrlich, 2014, Journal of pediatric urology.

Telomere Biology of Pediatric Cancer

J. Dome, U. Tabori, 2007, Cancer investigation.

Pediatric Solid Tumors

S. Spunt, C. Rodríguez-Galindo, J. Dome, 2020, Abeloff's Clinical Oncology.

Repeat nephron-sparing surgery for children with bilateral Wilms tumor.

A. Davidoff, L. McGregor, J. Dome, 2014, Journal of pediatric surgery.

An international strategy to determine the role of high dose therapy in recurrent Wilms' tumour.

D. Machin, K. Pritchard-Jones, J. Dome, 2013, European journal of cancer.

Wilms Tumor Overview

J. Dome, V. Huff, 2013 .

Clear cell sarcoma of the kidney: a review.

J. Dome, G. Vujanić, N. Graf, 2012, European journal of cancer.

Management of Wilms' tumour: current practice and future goals.

M. Coppes, J. Dome, P. Grundy, 2004, The Lancet. Oncology.

Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532

James R. Anderson, J. Dome, P. Grundy, 2017, Annals of surgery.

Chapter 25 – Renal Tumors

J. Dome, A. Warwick, 2016 .

Renal Tumors in Children

J. Dome, K. Vallance, 2014 .

Current and Emerging Chemotherapy Treatment Strategies for Wilms Tumor in North America

J. Dome, E. Gratias, 2008, Paediatric drugs.

DENYS–DRASH SYNDROME, FRASIER SYNDROME, AND WAGR SYNDROME ( WT1 ‐RELATED DISORDERS)

J. Dome, Joyce T. Turner, 2021 .

WT1 mutation and 11P15 loss of heterozygosity predict relapse in very low-risk wilms tumors treated with surgery alone: a children's oncology group study.

James R. Anderson, D. Green, J. Dome, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcomes based on histopathologic response to preoperative chemotherapy in children with bilateral Wilms tumor: A prospective study (COG AREN0534)

M. Chintagumpala, J. Dome, P. Grundy, 2022, Cancer.

Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report.

James R. Anderson, J. Gastier-Foster, J. Dome, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcome of patients with intracranial relapse enrolled on national Wilms Tumor Study Group clinical trials

M. Coppes, J. Dome, Yueh-Yun Chi, 2017, Pediatric blood & cancer.

Outcomes of children with favorable histology wilms tumor and peritoneal implants treated in National Wilms Tumor Studies-4 and -5.

James R. Anderson, D. Green, J. Dome, 2010, International journal of radiation oncology, biology, physics.

Revisiting the Threshold for Cancer Genetics Referral in Patients With Wilms Tumor.

J. Dome, D. A. Hill, Joyce T. Turner, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The HSP90 inhibitor alvespimycin enhances the potency of telomerase inhibition by imetelstat in human osteosarcoma

J. Dome, Jianping He, D. A. Hill, 2015, Cancer biology & therapy.

Analysis by array CGH of genomic changes associated with the progression or relapse of Wilms' tumour

A. Ashworth, J. Reis-Filho, R. Natrajan, 2007, The Journal of pathology.

Current therapy for Wilms' tumor.

J. Dome, M. Metzger, 2005, The oncologist.

Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.

James R. Anderson, J. Dome, P. Grundy, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The feasibility and outcome of nephron‐sparing surgery for children with bilateral Wilms tumor

A. Davidoff, J. Dome, F. Hoffer, 2008, Cancer.

Telomerase activity in the normal and neoplastic rat mammary gland.

S. Sukumar, L. Carey, C. Jiang, 1997, Cancer research.

White paper: Oncofertility in pediatric patients with Wilms tumor

A. Davidoff, J. Dome, N. Daw, 2022, International journal of cancer.

Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT

N. Zhang, P. Hanley, C. Bollard, 2022, Blood advances.

A genome-wide association study identifies susceptibility loci for Wilms tumor

S. Seal, N. Rahman, A. Naranjo, 2012, Nature Genetics.

Lymph node involvement in Wilms tumor: results from National Wilms Tumor Studies 4 and 5.

James R. Anderson, D. Green, A. Davidoff, 2012, Journal of pediatric surgery.

Incorporation of fluorescently labeled actin and tropomyosin into muscle cells.

J. Dome, J. Sanger, J. W. Sanger, 1988, Cell differentiation.

Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase

D. Campana, E. Coustan-Smith, J. Dome, 2003, British journal of haematology.

Systemic bevacizumab for end-stage juvenile recurrent respiratory papillomas: A case report.

D. Preciado, J. Dome, G. Zalzal, 2019, International Journal of Pediatric Otorhinolaryngology.

Targeting the HIF-1α-IGFBP2 axis therapeutically reduces IGF1-AKT signaling and blocks the growth and metastasis of relapsed anaplastic Wilms tumor

Yan Liu, J. Dome, Yang Liu, 2021, Oncogene.

Effect of telomerase inhibition on preclinical models of malignant rhabdoid tumor.

Yunbi Lu, J. Dome, Jianping He, 2014, Cancer genetics.

Outcomes of patients with revised stage I clear cell sarcoma of kidney treated in National Wilms Tumor Studies 1-5.

J. Dome, P. Grundy, E. Perlman, 2013, International journal of radiation oncology, biology, physics.

Comparison of diagnostic performance of CT and MRI for abdominal staging of pediatric renal tumors: a report from the Children’s Oncology Group

S. Servaes, A. Naranjo, J. Dome, 2014, Pediatric Radiology.

Surgical protocol violations in children with renal tumors provides an opportunity to improve pediatric cancer care: a report from the Children's Oncology Group

A. Naranjo, J. Dome, E. Perlman, 2016, Pediatric blood & cancer.

Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study.

James R. Anderson, J. Gastier-Foster, J. Dome, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase 1 trial of lyso-thermosensitive liposomal doxorubicin (LTLD) and magnetic resonance guided high intensity focused ultrasound (MR-HIFU) for pediatric refractory solid tumors.

N. Borys, R. Kaplan, L. Warner, 2017 .

Uncommon Pediatric Genitourinary Tumors

J. Dome, H. Pohl, B. Bambach, 2006 .

Treatment of metastatic rhabdoid tumor of the kidney.

C. Fuller, J. Dome, L. Wagner, 2002, Journal of pediatric hematology/oncology.

Disappearance of the Telomere Dysfunction-Induced Stress Response in Fully Senescent Cells

M. Kastan, C. Bakkenist, J. Dome, 2004, Cancer Research.

Telomere Shortening Alters the Kinetics of the DNA Damage Response after Ionizing Radiation in Human Cells

J. Dome, R. Drissi, Jing Wu, 2011, Cancer Prevention Research.

Giant cell tumor of bone with pulmonary metastases.

J. Dome, N. Daw, M. Neel, 2003, Medical and pediatric oncology.

A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study

J. Dome, E. Perlman, N. Daw, 2020, Cancer.

Telomerase activity in ductal carcinoma in situ and invasive breast cancer

S. Sukumar, L. Carey, M. Sherman, 1999, Oncogene.

The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing

D. Kirschmann, J. Dome, E. Perlman, 2018, Cancer.

Clinicopathologic findings predictive of relapse in children with stage III favorable-histology Wilms tumor.

N. Breslow, James R. Anderson, D. Green, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of the First Generation of Children's Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor.

M. Chintagumpala, J. Dome, P. Grundy, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Paediatric genitourinary cancers and late effects of treatment

J. Dome, M. Ritchey, K. Sadak, 2013, Nature Reviews Urology.

Principles and Practice of Pediatric Oncology (Fourth edition)

J. Dome, P. Grundy, E. Perlman, 2004 .

Delineation of a 1Mb breakpoint region at 1p13 in Wilms tumors by fine‐tiling oligonucleotide array CGH

A. Ashworth, A. Grigoriadis, R. Williams, 2007, Genes, chromosomes & cancer.

Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.

P. Meltzer, M. Ladanyi, E. Kleinerman, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Hypomethylation and hypermethylation of DNA in Wilms tumors

P. Laird, M. Widschwendter, M. Ehrlich, 2002, Oncogene.

A genome-wide association study identifies susceptibility loci for Wilms tumor

S. Seal, N. Rahman, A. Naranjo, 2012, Nature Genetics.

Non-Wilms Pediatric Renal Tumors

J. Dome, M. M. Heuvel‐Eibrink, S. Gooskens, 2014 .

Pharmacogenetic and clinical predictors of ondansetron failure in a diverse pediatric oncology population

P. Hinds, J. Dome, Jiaxiang Gai, 2021, Supportive Care in Cancer.

Aberrant activation, nuclear localization, and phosphorylation of yes‐associated protein‐1 in the embryonic kidney and Wilms tumor

James R. Anderson, M. D. de Caestecker, J. Dome, 2014, Pediatric blood & cancer.

Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.

N. Breslow, R. Macklis, D. Green, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chapter 70 – Wilms' Tumor

J. Dome, J. Kalapurakal, 2016 .

Simultaneous occurrence of Wilms tumor and rhabdomyosarcoma in two patients.

J. Dome, J. Jenkins, S. Muwakkit, 2002, Medical and pediatric oncology.

Molecular Characterization of the Pediatric Preclinical Testing Panel

J. Khan, T. Triche, J. Maris, 2008, Clinical Cancer Research.

Complex patterns of chromosome 9 alterations including the p16INK4a locus in Wilms tumours

J. Reis-Filho, R. Natrajan, K. Pritchard-Jones, 2007, Journal of Clinical Pathology.

TP53 Mutational Status Is a Potential Marker for Risk Stratification in Wilms Tumour with Diffuse Anaplasia

James R. Anderson, N. Sebire, T. Chagtai, 2014, PloS one.

Molecular profiling reveals frequent gain of MYCN and anaplasia‐specific loss of 4q and 14q in wilms tumor

A. Ashworth, James R. Anderson, T. Chagtai, 2011, Genes, chromosomes & cancer.

The Clinical Relevance of Age at Presentation in Nephroblastoma

K. Pritchard-Jones, J. Dome, N. Graf, 2016 .

Satellite DNA hypomethylation in karyotyped Wilms tumors.

Christian B. Woods, N. Hopkins, M. Ehrlich, 2003, Cancer genetics and cytogenetics.

Forty-five patient-derived xenografts capture the clinical and biological heterogeneity of Wilms tumor

Heather L. Mulder, P. Houghton, J. Rehg, 2019, Nature Communications.

Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms' tumor.

A. Letai, A. Naranjo, H. Steen, 2019, JCI insight.

Prohibitin is a prognostic marker of relapse and therapeutic target to block chemotherapy resistance in Wilms tumor

A. Letai, A. Naranjo, H. Steen, 2018 .

Outcome of patients with stage II/favorable histology wilms tumor with and without local tumor spill: A report from the National Wilms Tumor Study Group

N. Breslow, D. Green, A. Evans, 2014, Pediatric blood & cancer.

Careful histological confirmation and microdissection reveal telomerase activity in otherwise telomerase-negative breast cancers.

S. Sukumar, L. Carey, J. Dome, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor.

N. Breslow, S. Sukumar, L. Carey, 1999, Cancer research.

Kidney Preservation and Wilms Tumor Development in Children with Diffuse Hyperplastic Perilobar Nephroblastomatosis: A Report from the Children’s Oncology Group Study AREN0534

M. Chintagumpala, J. Dome, E. Perlman, 2022, Annals of Surgical Oncology.

DICER1 mutations in childhood cystic nephroma and its relationship to DICER1-renal sarcoma

Gretchen M. Williams, H. Cathro, P. Faria, 2014, Modern Pathology.

Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group.

James R. Anderson, J. Dome, P. Grundy, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

New approaches to risk stratification for Wilms tumor.

J. Dome, N. Graf, M. V. D. van den Heuvel-Eibrink, 2020, Current opinion in pediatrics.

Outcome analysis of stage I epithelial‐predominant favorable‐histology Wilms tumors: A report from Children's Oncology Group study AREN03B2

J. Dome, E. Perlman, Yeonil Kim, 2020, Cancer.

Children's Oncology Group's 2013 blueprint for research: Renal tumors

James R. Anderson, A. Naranjo, J. Dome, 2013, Pediatric blood & cancer.

Barriers to the Enrollment of Children in the Children's Oncology Group Study of Very Low Risk Wilms Tumor: A Report from the Children's Oncology Group

J. Dome, P. Grundy, P. Ehrlich, 2011, Journal of pediatric hematology/oncology.

Reply to B. Royer-Pokora et al

D. Green, J. Dome, P. Grundy, 2011 .

Detection of preoperative wilms tumor rupture with CT: a report from the Children's Oncology Group.

A. Naranjo, J. Dome, P. Grundy, 2013, Radiology.

Wilms Tumor Predisposition

J. Dome, V. Huff, 2016 .

Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis

J. Dome, A. Perantoni, S. Plisov, 2006, Oncogene.

ELR+-CXC chemokines and their receptors in early metanephric development.

J. Dome, A. Perantoni, N. Sharma, 2007, Journal of the American Society of Nephrology : JASN.

Telomerase expression predicts unfavorable outcome in osteosarcoma.

M. Valentine, J. Dome, N. Daw, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors

P. Hinds, C. Rodríguez-Galindo, W. London, 2021, Pediatric blood & cancer.

Reopening Schools Safely: The Case for Collaboration, Constructive Disruption of Pre-Coronavirus 2019 Expectations, and Creative Solutions

L. Ross, C. Byington, L. Guay-Woodford, 2020, The Journal of Pediatrics.

Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factor.

N. Breslow, D. Green, G. Tomlinson, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma—A Children's Oncology Group study

Rachel A. Kudgus, Steve Y. Cho, Malcolm A. Smith, 2020, Cancer.

Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology Group

M. Chintagumpala, J. Dome, P. Grundy, 2020, Cancer.

Immunotherapy of Relapsed and Refractory Solid Tumors With Ex Vivo Expanded Multiantigen-Associated Specific Cytotoxic T Lymphocytes: A Phase I Study.

S. Darko, P. Hanley, C. Cruz, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of Refractory Osteosarcoma With Fractionated Cyclophosphamide and Etoposide

A. Pappo, C. Rodríguez-Galindo, J. Dome, 2002, Journal of pediatric hematology/oncology.

Summary of COVID‐19 clinical practice adjustments across select institutions

M. Link, D. Hawkins, A. Kung, 2020, Pediatric Blood & Cancer.

Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma

J. Dome, J. Geller, 2004, Cancer.

Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma.

W. Linehan, W. Rathmell, M. Atkins, 2019, Clinical genitourinary cancer.

Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study.

J. Dome, P. Grundy, E. Perlman, 2019, European journal of cancer.

Clinical and biologic significance of nuclear unrest in Wilms tumor

Torin D. Shear, J. Dome, Tiebin Liu, 2003, Cancer.

Complete response of recurrent cellular congenital mesoblastic nephroma to chemotherapy.

J. Dome, D. A. Hill, D. Loeb, 2002, Journal of pediatric hematology/oncology.

Identification and Management of High Risk Wilms Tumors

J. Dome, 2009 .

MLLT1 YEATS domain mutations in clinically distinctive Favourable Histology Wilms tumours

Richard A. Moore, Daoud M. Meerzaman, D. Wheeler, 2015, Nature Communications.

Strategy for management of retroperitoneal tumors with caval tumor thrombus.

J. Dome, P. Guzzetta, P. Sinha, 2011, Journal of pediatric surgery.

A prospective study of pediatric renal cell carcinoma: A report from the Children’s Oncology Group study AREN0321.

J. Dome, E. Perlman, N. Daw, 2018 .

Subsets of Very Low Risk Wilms Tumor Show Distinctive Gene Expression, Histologic, and Clinical Features

Norman Breslow, Chiang-Ching Huang, N. Breslow, 2009, Clinical Cancer Research.

BRAF V600E-mutated metastatic pediatric Wilms tumor with complete response to targeted RAF/MEK inhibition

P. Argani, C. Pratilas, A. Friedman, 2020, Cold Spring Harbor molecular case studies.

High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor.

N. Breslow, D. Green, J. Dome, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study.

Chiang-Ching Huang, D. Green, S. Gadd, 2012, Neoplasia.

Erratum to Recurrent DGCR8, DROSHA, and SIX Homeodomain Mutations in Favorable Histology Wilms Tumors [Cancer Cell., 27, 286-297 (2015)] DOI: 10.1016/j.ccell.2015.02.008

Richard A. Moore, D. Wheeler, D. Gerhard, 2015 .

Gain of 1q is associated with inferior event‐free and overall survival in patients with favorable histology Wilms tumor: A report from the Children's Oncology Group

James R. Anderson, J. Dome, P. Grundy, 2013, Cancer.

Blastemal expression of type I insulin-like growth factor receptor in Wilms' tumors is driven by increased copy number and correlates with relapse.

J. Reis-Filho, Chris Jones, R. Natrajan, 2006, Cancer research.

Pediatric cystic nephromas: distinctive features and frequent DICER1 mutations.

J. Dome, E. Perlman, Lan Gellert, 2016, Human pathology.

Management of adults with Wilms’ tumor: recommendations based on international consensus

G. Gatta, M. Coppes, K. Pritchard-Jones, 2011, Expert review of anticancer therapy.

Advances in the clinical management of high‐risk Wilms tumors

J. Dome, J. Brok, A. Mavinkurve-Groothuis, 2023, Pediatric blood & cancer.

Imaging Characteristics of Nephrogenic Rests Versus Small Wilms Tumors: A Report From the Children's Oncology Group Study AREN03B2.

J. Sandberg, S. Servaes, J. Dome, 2020, AJR. American journal of roentgenology.

Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study.

James R. Anderson, J. Dome, P. Grundy, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of Surveillance Imaging Modality on Survival After Recurrence in Patients With Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group.

James R. Anderson, D. Green, J. Dome, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Loss of Heterozygosity at 2q37 in Sporadic Wilms' Tumor: Putative Role for miR-562

M. Gessler, Chris Jones, R. Natrajan, 2009, Clinical Cancer Research.

Congenital mesoblastic nephroma 50 years after its recognition: A narrative review

K. Pritchard-Jones, J. Dome, G. Vujanić, 2017, Pediatric blood & cancer.

Genomic Loss of Tumor Suppressor miRNA-204 Promotes Cancer Cell Migration and Invasion by Activating AKT/mTOR/Rac1 Signaling and Actin Reorganization

A. Pertsemlidis, R. Broaddus, Yidong Chen, 2012, PloS one.

Occurrence of fibers and their association with talin in the cleavage furrows of PtK2 cells.

J. Dome, J. Sanger, J. W. Sanger, 1994, Cell motility and the cytoskeleton.

Cefixime allows greater dose escalation of oral irinotecan: a phase I study in pediatric patients with refractory solid tumors.

P. Houghton, J. Panetta, C. Rodríguez-Galindo, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hepatic Metastasis at Diagnosis in Patients With Wilms Tumor is not an Independent Adverse Prognostic Factor for Stage IV Wilms Tumor: A Report From the Children's Oncology Group/National Wilms Tumor Study Group

James R. Anderson, D. Green, J. Dome, 2009, Annals of surgery.

Anthropomorphic measurements and event‐free survival in patients with favorable histology Wilms tumor: A report from the Children's Oncology Group

James R. Anderson, D. Green, J. Dome, 2009, Pediatric blood & cancer.

The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition: A Report from the Children's Oncology Group AREN18B5-Q Study

Heather L. Mulder, B. Crompton, Zhaoming Wang, 2023, Research square.

Treatment of recurrent clear cell sarcoma of the kidney with brain metastasis

L. Diller, C. Moertel, J. Dome, 2008, Pediatric blood & cancer.

Advances in the clinical management of high‐risk Wilms tumors

J. Dome, J. Brok, A. Mavinkurve-Groothuis, 2023, Pediatric blood & cancer.

Improved Survival for Patients With Recurrent Wilms Tumor: The Experience at St. Jude Children's Research Hospital

J. Dome, N. Daw, Tiebin Liu, 2002, Journal of pediatric hematology/oncology.

Breast cancer in Wilms tumor survivors: New insights into primary and secondary prevention

J. Dome, J. Dean, 2014, Cancer.

A phase 2 study of vincristine and irinotecan in metastatic diffuse anaplastic Wilms tumor: Results from the Children’s Oncology Group AREN0321 study.

James R. Anderson, J. Dome, P. Grundy, 2014 .

Clinical outcome and biological predictors of relapse following nephrectomy only for very low risk Wilms tumor (VLR WT): A report from Children’s Oncology Group AREN0532.

James R. Anderson, J. Dome, P. Grundy, 2015 .

Inflammatory myofibroblastic tumor as a second neoplasm after Wilms tumor

J. Dome, D. A. Hill, F. Qureshi, 2015, Pediatric blood & cancer.

Treatment of stage IV malignant rhabdoid tumor of the kidney (MRTK) with ICE and VDCy: a case report.

H. Tsutsumi, M. Hareyama, J. Dome, 2006, Journal of pediatric hematology/oncology.

A genome-wide association study identifies susceptibility loci for Wilms tumor

S. Seal, N. Rahman, A. Naranjo, 2012, Nature Genetics.

Omission of lung radiation in patients with stage IV favorable histology Wilms Tumor (FHWT) showing complete lung nodule response after chemotherapy: A report from Children's Oncology Group study AREN0533.

James R. Anderson, J. Dome, P. Grundy, 2015 .

Treatment of stage IV favorable histology Wilms tumor with incomplete lung metastasis response after chemotherapy: A report from Children's Oncology Group study AREN0533.

James R. Anderson, J. Dome, P. Grundy, 2014 .

Adjuvant therapy in pediatric patients with completely resected renal cell carcinoma

J. Dome, J. Geller, 2006, Pediatric blood & cancer.

Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors.

P. Hinds, C. Rodríguez-Galindo, W. London, 2014 .

Principles and Practice of Pediatric Oncology (Fifth edition)

J. Dome, P. Grundy, E. Perlman, 2006 .

Significance of pleural effusion at diagnosis of Wilms tumor

A. Davidoff, J. Dome, J. Wilimas, 2004, Pediatric blood & cancer.

Hallmark discoveries in the biology of Wilms tumour.

D. Gisselsson, R. Williams, J. Drost, 2023, Nature reviews. Urology.

Gain of 1q is associated with inferior event‐free and overall survival in patients with favorable histology Wilms tumor: A report from the Children's Oncology Group

James R. Anderson, J. Dome, P. Grundy, 2013, Cancer.

Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children’s Oncology Group AREN18B5-Q

B. Crompton, Xiang Chen, Ninad Oak, 2023, Nature communications.

Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.

James R. Anderson, J. Dome, P. Grundy, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: A report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS‐5

J. Dome, P. Grundy, J. Geller, 2023, Cancer.

Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children's Oncology Group Studies AREN03B2 and AREN0532.

J. Dome, J. Geller, J. Kalapurakal, 2023, Cancer.

Treatment and outcomes of clear cell sarcoma of the kidney: A report from the Children's Oncology Group studies AREN0321 and AREN03B2

J. Dome, P. Grundy, N. Daw, 2024, Cancer.

Effect of telomerase inhibition on preclinical models of malignant rhabdoid tumor.

Yunbi Lu, J. Dome, Jianping He, 2014, Cancer genetics.

Lymph node involvement in Wilms tumor: results from National Wilms Tumor Studies 4 and 5.

James R. Anderson, A. Davidoff, J. Dome, 2012, Journal of pediatric surgery.